Pradaxa Achieves Blockbuster Status
This is Michael Brady Lynch, Lead Trial Attorney for The Michael Brady Lynch Firm. It was with great fanfare that Pradaxa manufacturer Boehringer Ingelheim Pharmaceuticals announced last week that Pradaxa had achieved the status of a “blockbuster drug” (blockbuster status is defined as generating annual sales of $1 billion or more). Ironically, this announcement comes on the
Read MoreMichael Brady Lynch to Lecture on Pradaxa Bleeding Dangers
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. It looks like the bleeding risks of the drug Pradaxa is going to be taking up a lot of my time over the next few years. Pradaxa is truly an awful case of corporate malfeasance and putting profits over patient safety. One
Read MoreProzac & Lexapro Birth Defects: Different Drugs, Same Devastated Lives
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Being at the forefront of litigation involving SSRIs and birth defects, I am fortunate that I have so many attorneys refer me their cases involving SSRI birth defects involving drugs such as Lexapro and Prozac. It is gratifying that these referring
Read MoreInjury Spotlight: Vaginal Mesh Complications
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Almost every day, I speak with another woman who has experienced devastating complications following the implant of a vaginal mesh or sling. From extreme pain during intercourse to bleeding and infection, the risks of this “product gone wrong” so far outweigh
Read More